Skip to main content

Physicians for Reproductive Health Urges Supreme Court to Stay District Court’s Ruling on Medication Abortion

Press releases | April 17, 2023

On Friday, April 14, Fried Frank filed an amicus brief in the US Supreme Court on behalf of Physicians for Reproductive Health (PRH), a physician-led national advocacy organization that organizes, mobilizes and amplifies the voices of medical providers to advance sexual and reproductive health, rights and justice. The brief urges the Supreme Court to grant pending stay applications of Judge Matthew Kacsmaryk’s order attempting to void the US Food and Drug Administration’s approval of mifepristone, a drug used in medication abortion.

The brief argues that the proven safety and efficacy of mifepristone allows providers to obtain informed consent from patients, and restricting access to mifepristone interferes with the ethical obligations of providers to respect patient autonomy and provide safe and effective care.

The brief states, “the medical evidence on safety available at the time mifepristone was first FDA-approved is consistent with the additional evidence available today: mifepristone is proven to be safe and effective for medication abortion up to (at a minimum) ten weeks gestation as well as later-term miscarriage management and management of fetal demise later in pregnancy. Two decades of medical evidence and provider experience supports the FDA’s approval and subsequent changes to the risk evaluation and mitigation strategies, and this Court should not allow the lower courts to second-guess the expert judgment of the FDA.”

Further, “for over twenty years, providers have included the mifepristone-misoprostol regimen used in medication abortion among the range of options for patients seeking abortion care, but the orders below jeopardize that care. In the absence of a stay from this Court, providers treating patients who want a medication abortion with mifepristone may be forced to withhold a valid and safe option, disregarding patient autonomy – a violation of medical ethics – or potentially violating the law.”

The full brief is available here.

The Fried Frank team included partner Janice Mac Avoy, special counsel Laura Israel Sinrod, associates Anne Aufhauser, Dylan B. Bolduc and Alexis Casamassima and law clerk Lucretia Bunzel. 

Fried Frank prepared the brief, as well as the affiliated amicus brief in the US Court of Appeals for the Fifth Circuit, in partnership with the Center for Reproductive Rights, a global legal advocacy organization that seeks to advance reproductive rights, including abortion.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.